882 related articles for article (PubMed ID: 33779742)
21. Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.
; Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; Evans JS; Russell B; Harbeck N; Vincenzi B; Biello F; Bertulli R; Ottaviani D; Liñan R; Rossi S; Carmona-García MC; Tondini C; Fox L; Baggi A; Fotia V; Parisi A; Porzio G; Queirolo P; Cruz CA; Saoudi-Gonzalez N; Felip E; Roqué Lloveras A; Newsom-Davis T; Sharkey R; Roldán E; Reyes R; Zoratto F; Earnshaw I; Ferrante D; Marco-Hernández J; Ruiz-Camps I; Gaidano G; Patriarca A; Bruna R; Sureda A; Martinez-Vila C; Sanchez de Torre A; Berardi R; Giusti R; Mazzoni F; Guida A; Rimassa L; Chiudinelli L; Franchi M; Krengli M; Santoro A; Prat A; Tabernero J; Van Hemelrijck M; Diamantis N; Gennari A; Cortellini A
JAMA Oncol; 2022 Jan; 8(1):114-122. PubMed ID: 34817562
[TBL] [Abstract][Full Text] [Related]
22. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
[TBL] [Abstract][Full Text] [Related]
23. Good clinical practice and the use of hypofractionation radiation schedules as weapons to reduce the risk of COVID-19 infections in radiation oncology unit: A mono-institutional experience.
Cozzi S; Ruggieri MP; Bardoscia L; Najafi M; Blandino G; Giaccherini L; Manicone M; Ramundo D; Rosca A; Solla DS; Botti A; Lambertini D; Ciammella P; Iotti C
J Cancer Res Ther; 2023; 19(3):644-649. PubMed ID: 37470588
[TBL] [Abstract][Full Text] [Related]
24. Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance.
Oertel M; Elsayad K; Engenhart-Cabillic R; Reinartz G; Baues C; Schmidberger H; Vordermark D; Marnitz S; Lukas P; Ruebe C; Engert A; Lenz G; Eich HT
Strahlenther Onkol; 2020 Dec; 196(12):1096-1102. PubMed ID: 33125504
[TBL] [Abstract][Full Text] [Related]
25. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic.
Oladeru OT; Dunn SA; Li J; Coles CE; Yamauchi C; Chang JS; Cheng SH; Kaidar-Person O; Meattini I; Ramiah D; Kirby A; Hijal T; Marta GN; Poortmans P; Isern-Verdum J; Zissiadis Y; Offersen BV; Refaat T; Elsayad K; Hijazi H; Dengina N; Belkacemi Y; Luo FD; Lu S; Griffin C; Collins M; Ryan P; Larios D; Warren LE; Punglia RS; Wong JS; Spiegel DY; Jagsi R; Taghian A; Bellon JR; Ho AY
JCO Glob Oncol; 2023 Jul; 9():e2300010. PubMed ID: 37471670
[TBL] [Abstract][Full Text] [Related]
26. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
27. How will the CHHiP trial affect the future of prostate radiotherapy?
Dearnaley D; Hall E
Expert Rev Anticancer Ther; 2018 Jul; 18(7):607-609. PubMed ID: 29774771
[No Abstract] [Full Text] [Related]
28. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
29. Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.
Kalbasi A; Li J; Berman A; Swisher-McClure S; Smaldone M; Uzzo RG; Small DS; Mitra N; Bekelman JE
JAMA Oncol; 2015 Oct; 1(7):897-906. PubMed ID: 26181727
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
31. Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era.
Gupta T; Ghosh-Laskar S; Agarwal JP
Oral Oncol; 2020 Dec; 111():105045. PubMed ID: 33091846
[TBL] [Abstract][Full Text] [Related]
32. Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer.
Lilleby W; Kishan A; Geinitz H
World J Urol; 2024 Jan; 42(1):41. PubMed ID: 38244053
[TBL] [Abstract][Full Text] [Related]
33. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
[TBL] [Abstract][Full Text] [Related]
34. Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
Jagsi R; Griffith KA; Vicini FA; Abu-Isa E; Bergsma D; Bhatt A; Dilworth JT; Dominello M; Franklin S; Heimburger DK; Kaufman I; Kocheril PG; Kretzler AE; Paximadis P; Radawski JD; Walker EM; Pierce L
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):853-860. PubMed ID: 34718094
[TBL] [Abstract][Full Text] [Related]
35. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.
Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M
JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202
[TBL] [Abstract][Full Text] [Related]
36. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer.
Meattini I; Becherini C; Boersma L; Kaidar-Person O; Marta GN; Montero A; Offersen BV; Aznar MC; Belka C; Brunt AM; Dicuonzo S; Franco P; Krause M; MacKenzie M; Marinko T; Marrazzo L; Ratosa I; Scholten A; Senkus E; Stobart H; Poortmans P; Coles CE
Lancet Oncol; 2022 Jan; 23(1):e21-e31. PubMed ID: 34973228
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation.
Williams VM; Kahn JM; Harkenrider MM; Chino J; Chen J; Fang LC; Dunn EF; Fields E; Mayadev JS; Rengan R; Petereit D; Dyer BA
Brachytherapy; 2020; 19(4):401-411. PubMed ID: 32359937
[TBL] [Abstract][Full Text] [Related]
38. Hypofractionated radiation treatment in the management of breast cancer.
Gupta A; Ohri N; Haffty BG
Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
[TBL] [Abstract][Full Text] [Related]
39. Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer.
Zaorsky NG; Shaikh T; Murphy CT; Hallman MA; Hayes SB; Sobczak ML; Horwitz EM
Cancer Treat Rev; 2016 Jul; 48():50-60. PubMed ID: 27347670
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
